Search
for
Sort by
Research 361–390 of 1000+
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- The Effects of Estradiol, Androgens and the Selective Estrogen Modulators: Ospemifene, Raloxifene and Tamoxifen on Explant Cultures of Human Breast Tissue
- Development of a FRET-based 3D in vitro breast tumor model and its application in evaluating drug-induced apoptosis
- A Transition State Analogue of 5′-Methylthioadenosine Phosphorylase Induces Apoptosis in Head and Neck Cancers
- A Cellular Study of Inflammatory Responses in Women with Polycystic Ovary Syndrome as: “An In vitro Model of Anti Breast Tumor Response”A Case Control Study
- Oral minoxidil for late alopecia in cancer survivors
- News in brief
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Breast implant illness: a topic in review
- Expression of a truncated form of hHb1 hair keratin in human breast carcinomas
- Case Study: Hereditary Cancer Genetic Testing in Unaffected Patients May Allow for Early Intervention and Aggressive Management
- RANK as a therapeutic target in cancer
- Association of Spironolactone Use With Risk of Cancer
- (024) Monitored Hormone Therapy in Women 70 Years and Older: Aging Does Not Mean Sexual Retirement
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- Certain Cancer Myths Endure, with Impact on Treatment, Prevention, Screening
- Breast Implant-Associated Immunological Disorders
- Cancer Treatment, Symptom Monitoring, and Self-care in Adults
- Bladder Cancer: The Hormonal Dependence Enigma and a New Hormonal Player
- KRT17: A Key Driver of Cancer Therapy Resistance and Emerging Therapeutic Target
- Tracing the cellular origin of cancer
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article
- Regenerative Medicine to Reduce the Side Effects from Radiotherapy Causing Skin Cancer, Fibrosis, Neuropathic Pain and Hair Loss
- Liposomes in cancer therapy
- 12-Chloracetyl-PPD, a novel dammarane derivative, shows anti-cancer activity via delay the progression of cell cycle G2/M phase and reactive oxygen species-mediate cell apoptosis
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
- Abstract 1: A Cost-Utility Analysis Comparing Oncoplastic Breast Surgery with Standard Lumpectomy in Large Breasted Women
- Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties